(19)
(11) EP 1 651 235 A2

(12)

(88) Date of publication A3:
07.07.2005

(43) Date of publication:
03.05.2006 Bulletin 2006/18

(21) Application number: 04757425.6

(22) Date of filing: 05.08.2004
(51) International Patent Classification (IPC): 
A61K 31/56(1985.01)
(86) International application number:
PCT/US2004/025295
(87) International publication number:
WO 2005/016276 (24.02.2005 Gazette 2005/08)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL HR LT LV MK

(30) Priority: 05.08.2003 US 492769 P

(71) Applicants:
  • Samaritan Pharmaceuticals, Inc.
    Las Vegas, NV 89109 (US)
  • GEORGETOWN UNIVERSITY
    Washington, DC 20007-1408 (US)
  • Papadopoulos, Vassilios
    North Potomac, MD 20878 (US)
  • Lecanu, Laurent
    McLean, VA 22102 (US)
  • Greeson, Janet
    Las Vegas, NV 89109 (US)

(72) Inventors:
  • PAPADOPOULOS, Vassilios
    North Potomac, MD 20878 (US)
  • LECANU, Laurent
    McLean, VA 22102 (US)
  • GREESON, Janet
    Las Vegas, NV 89109 (US)

(74) Representative: Lucas, Brian Ronald et al
Lucas & Co. 135 Westhall Road
Warlingham Surrey CR6 9HJ
Warlingham Surrey CR6 9HJ (GB)

   


(54) SIGMA-1 RECEPTOR LIGAND WITH ACETYLCHOLINESTERASE INHIBITION PROPERTIES